Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gregory Michael Cote, M.D.

Co-Author

This page shows the publications co-authored by Gregory Cote and Patrick Wen.
Connection Strength

0.468
  1. Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial. Clin Cancer Res. 2021 Aug 15; 27(16):4491-4499.
    View in: PubMed
    Score: 0.242
  2. Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Advanced Glioma. J Clin Oncol. 2020 10 10; 38(29):3398-3406.
    View in: PubMed
    Score: 0.226
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.